Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hurricane season loss trends, asbestos reserve movements, and commercial premium pricing make Travelers Companies filings uniquely data-rich. Whether you’re comparing combined ratios or tracking how management prices catastrophe reinsurance, every 10-K and 10-Q reveals insights that drive this insurer’s results.
Stock Titan’s AI turns those dense disclosures into clarity. Need the Travelers Companies quarterly earnings report 10-Q filing in plain language? Our AI-powered summaries highlight net written premium growth, reserve development, and investment portfolio yields in seconds. Wondering about Travelers Companies insider trading Form 4 transactions? Receive real-time alerts the moment executives buy or sell shares, with context around claim seasonality and capital returns.
- Annual report 10-K simplified – pinpoint catastrophe exposure tables, statutory surplus data, and segment profitability without scrolling 300 pages.
- 8-K material events explained – understand dividend declarations, hurricane loss estimates, or senior note offerings minutes after EDGAR posts.
- Proxy statement executive compensation – see how combined ratio targets drive bonus pools and compare CEO pay to peers.
- Form 4 insider transactions real-time – follow underwriting leadership’s trades to gauge confidence in reserve adequacy.
Our coverage spans every filing type, from Travelers Companies earnings report filing analysis to shelf registrations. AI-driven search answers natural questions like “How to read Travelers Companies 10-K” or “Where can I find Travelers Companies executive stock transactions Form 4.” Stop wading through actuarial jargon; understand Travelers Companies SEC filings explained simply with concise takeaways, expert context, and live updates that surface what matters most to property-casualty investors.
The Travelers Companies, Inc. director reported receiving additional deferred common stock units instead of cash fees. On 12/31/2025, the director acquired 150.83 deferred common stock units at a reference price of $290.06 per share, bringing the total directly owned deferred units to 11,457.626.
These deferred common stock units are granted under the company’s Deferred Compensation Plan for Non-Employee Directors and related director compensation plans. Each unit will convert on a one-for-one basis into a share of Travelers common stock when distributions are made. The director can elect to receive distributions in a lump sum or in annual installments, and the total includes 42.719 units added on December 31, 2025 through dividend reinvestment features.
The Travelers Companies, Inc. reported that one of its directors acquired deferred common stock units instead of cash fees. On 12/31/2025, the director received 159.45 deferred common stock units of Travelers common stock at a price of $290.06 per share, bringing the director’s total beneficial holding to 4,531.663 deferred common stock units.
According to the company’s Deferred Compensation Plan for Non-Employee Directors, these units will convert into shares of Travelers common stock on a one-for-one basis at distribution. Distribution occurs, at the director’s election, either in a lump sum or in annual installments. The filing also notes that the total includes 16.52 deferred common stock units acquired on December 31, 2025 through dividend reinvestment features of the directors’ compensation plans.
The Travelers Companies, Inc. executive reports equity disposition and updated holdings. A Form 4 filing shows that an officer of Travelers, serving as EVP and Chief Admin Officer, reported a transaction in the company’s common stock on 11/26/2025. The transaction, coded “G,” involved the disposition of 400 shares of common stock at a stated price of $0.
After this transaction, the reporting person beneficially owns 20,291.577 shares of Travelers common stock in a direct account and 1,702.641 shares through a 401(k) plan. The filing is made by one reporting person and reflects an update to that individual’s ownership position in Travelers stock.
The Travelers Companies, Inc. (TRV)11/25/2025, the executive exercised stock options to acquire 4,000 shares of common stock at an exercise price of $172.50 per share (coded as an "M" transaction). On the same date, the executive sold 2,000 shares at a weighted average price of $293.505 per share, 1,000 shares at $295, and 1,000 shares at $296 (all coded as "S" for sales).
After these transactions, the executive directly beneficially owned 255,085.534 shares of Travelers common stock. Additional indirect holdings included 1,710.706 shares in a 401(k) plan, 2,256 shares held by a spouse, and 250 shares held in trust for a stepson, with the executive disclaiming beneficial ownership of the spouse and trust shares.
The Travelers Companies, Inc. (TRV) executive reports share transfer. An officer of the company, listed as EVP, Strategic Development & President International, filed a Form 4 for a transaction dated 11/25/2025. The filing shows a Code G transaction, indicating a gift of 520 shares of common stock at a reported price of
Following this transaction, the reporting person beneficially owns 117,596.149 shares of Travelers common stock in direct form and 340.501 shares held indirectly through a 401(k) plan. This is a routine insider ownership update and does not change the company’s overall capital structure.
The Travelers Companies, Inc. (TRV)William H. Heyman filed a Form 144 notice covering a proposed sale of 4,000 shares of TRV common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of
The notice also lists prior sales of TRV common stock for the same seller during the past three months, including 4,000 shares on
The Travelers Companies, Inc. (TRV) reported an insider transaction by its EVP & Chief HR Officer on 11/24/2025. The executive exercised stock options to acquire 4,805 shares of common stock at an exercise price of $126.18 per share, then sold 4,805 shares of common stock at a price of $290 per share the same day.
After these transactions, the executive directly owned 3,818.549 shares of Travelers common stock. The related stock option grant, which was exercisable from 02/05/2022 and scheduled to expire on 02/05/2029, now shows 0 derivative securities remaining beneficially owned.
The Travelers Companies, Inc. (TRV)11/21/2025, the insider exercised 5,000 stock options at an exercise price of $126.18 per share, acquiring common stock. That same day, the insider sold 5,000 shares of common stock at a weighted average price of $290.5698 per share, as noted in the footnotes.
After these transactions, the insider beneficially owned 22,562.385 shares of TRV common stock directly at one point following the option exercise, with the Form 4 showing 17,562.385 shares directly owned after the reported sale. Additional indirect holdings include 5,860.345 shares in a 401(k) plan and 9,986 shares held in trust, indicating continued significant ownership alignment with shareholders.
The Travelers Companies, Inc. (TRV)11/21/2025, the officer exercised 2,000 stock options at an exercise price of $172.50 per share and acquired the same number of common shares. That day, the officer also sold 1,000 shares at $291 and 1,000 shares at $292.
After these transactions, the officer directly owned 255,085.534 shares of Travelers common stock and held additional indirect interests, including shares in a 401(k) plan, shares held by a spouse, and shares held in trust for a stepson. The filing notes that the reporting person disclaims beneficial ownership of certain indirectly held shares.
TRV has a notice of proposed sale of common stock under Rule 144. The seller plans to sell 4,805 shares of common stock on the NYSE through Fidelity Brokerage Services LLC, with an aggregate market value of $1,393,450.00. The table notes that 223,063,417 shares of this class were outstanding at the time referenced.
The shares to be sold were acquired on 11/24/2025 through an option that was originally granted on 02/05/2019, with the purchase price paid in cash on the acquisition date. By signing the notice, the seller represents that they are not aware of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed and acknowledges the criminal penalties for intentional misstatements or omissions.